cro.directory
← Home
Protheragen logo

Protheragen

End-to-end preclinical and clinical CRO specializing in obesity therapeutics development.

Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Phases

Indications / Therapeutic Areas

Services

Modalities

Technical specifications & accreditations

About this organization

Protheragen is a contract research organization (CRO) focused exclusively on preclinical and clinical research for obesity therapeutics. The company provides an integrated obesity research platform spanning discovery, preclinical development, and clinical support services.

Core Capabilities

Preclinical Services:

  • Obesity models that replicate obesity-related conditions
  • Pharmacodynamic studies assessing biological effects and mechanisms of action
  • Pharmacokinetic studies evaluating drug absorption, distribution, metabolism, and excretion
  • Bioanalysis using advanced techniques to quantify drug concentrations
  • Safety assessment and toxicological evaluation
  • Custom research services tailored to client needs

Target Selection & Drug Development:

  • Expertise across hormones and peptides (leptin, adiponectin, ghrelin, GLP-1, amylin, exendin)
  • Receptor targeting (MC4R, PPARs, serotonin, cannabinoid, orexin, glucagon, GIP)
  • Enzyme and protein targets
  • Metabolic regulators and signaling molecules
  • Mitochondrial targets
  • Support for small molecule, gene therapy, cell therapy, antibody, tissue engineering, and nanotherapy modalities

Clinical & Regulatory Support:

  • Regulatory affairs and submission support
  • Clinical development strategy and medical writing
  • Early phase clinical pharmacology
  • Clinical operations and trial management
  • Site management and patient recruitment
  • Data management and biostatistics
  • Pharmacovigilance and risk management
  • Post-marketing evidence and market access (RWE/HEOR)

Commitment

Protheragen emphasizes GLP/GMP compliance, quality assurance, and regulatory acceptance of data. The company employs a multidisciplinary approach integrating metabolism, inflammation, and cardiovascular biology expertise, working collaboratively with clients to deliver tailored solutions that accelerate obesity drug development timelines.

Similar profiles by shared services, phases, and indications.

View all alternatives →See similar CROs ranked by shared capabilities

Submit a verified review for this organization.

Markdown mirror: /companies/obesityscientific.md